Wedge Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Wedge Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-32,900	Closed	-$1.1M	–	615
2017 Q2	$1.1M	Sell	32,900 -4,200	-11%	-$125K	0.01%	326
2017 Q1	$1.07M	Sell	37,100 -4,800	-11%	-$119K	0.01%	322
2016 Q4	$936K	Hold	41,900	–	–	0.01%	344
2016 Q3	$778K	Sell	41,900 -8,400	-17%	-$158K	0.01%	360
2016 Q2	$820K	Sell	50,300 -19,300	-28%	-$284K	0.01%	347
2016 Q1	$813K	Buy	69,600 +4,900	+8%	+$54.8K	0.01%	348
2015 Q4	$756K	Hold	64,700	–	–	0.01%	371
2015 Q3	$792K	Sell	64,700 -48,500	-43%	-$618K	0.01%	364
2015 Q2	$1.07M	Buy	113,200 +82,400	+268%	+$762K	0.01%	311
2015 Q1	$273K	Buy	+30,800	New	+$311K	﹤0.01%	547

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wedge Capital Management's BEAT Position: Q3 2017 in Review

Wedge Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 32,900 shares — an estimated $1.1M sold.

Wedge Capital Management first reported a position in BEAT in Q1 2015 and held it in 10 quarters. The position peaked at $1.1M in Q2 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

Wedge Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
Wedge Capital Management sold 32,900 BioTelemetry, Inc. shares in Q3 2017, an estimated $1.1M.
Wedge Capital Management first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 10 quarters.
Wedge Capital Management's BioTelemetry, Inc. position peaked at $1.1M in Q2 2017.
211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Wedge Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.